Matt’s Take
Matthew Herper is a senior medicine writer at STAT. He has covered medical innovation for decades, joining STAT in 2019 after 18 years at Forbes. In addition to writing news and columns, he also directs the editorial aspects of STAT’s events, including our highly regarded summits.
Latest
STAT Plus: Over-the-counter Sudafed PE doesn’t work. Neither does our system for evaluating older drugs
STAT Plus: What past blockbusters can tell us about future of Wegovy and other weight loss medicines
STAT Plus: From drug shortages to high prices, U.S. system’s shortcomings have deep roots
STAT Plus: Francis deSouza’s tenure at Illumina is a lesson in how not to handle CEO succession
STAT Plus: Battle for the soul of Illumina is also a referendum on its CEO
STAT Plus: Bernie Sanders’ accidentally great drug pricing idea
Here’s why we’re not prepared for the next wave of biotech innovation
All Coverage
advertisement
